drugset / Trial / NCT00919607
Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients
RandomizedSingle-groupOpen-label
Summary
The primary objective of the study is to evaluate the pharmacokinetics of XR quetiapine fumarate(300mg,600mg,and 800mg once-daily) in Chinese schizophrenic patients .
Timeline
- Start
- 2009-06
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 200 mg | Oral |
| Subject | Quetiapine | Small molecule | 300 mg | Oral |
| Subject | Quetiapine | Small molecule | 600 mg | Oral |
| Subject | Quetiapine | Small molecule | 800 mg | Oral |